Secondary Polycythemia in Hepatocellular Carcinoma: Treat or No Treat

Authors

  • Poernomo Budi Setiawan Division of Gastroentero-hepatology, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga/Dr Soetomo General Hospital, Surabaya
  • Ummi Maimunah Division of Gastroentero-hepatology, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga/Dr Soetomo General Hospital, Surabaya
  • Nenci Siagian Division of Gastroentero-hepatology, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga/Dr Soetomo General Hospital, Surabaya

DOI:

https://doi.org/10.24871/211202064-67

Keywords:

hepatocellular carcinoma (HCC), polycythemial, trans arterial chemotherapy and embolization (TACE)

Abstract

A 45-year man with a chronic hepatitis B virus (HBV) infection, elevated alphafetoprotein (AFP) 628ng/dL and Abdominal CT-scan features of Hepatocellular Carcinoma was admitted with polycythemia condition (haemoglobin 20.4g/dL, haematocrit 65.4%). Elevated of erythropoietin (EPO) serum level confirmed the polycythemia was because of hepatocellular carcinoma (HCC) as a paraneoplastic syndrome. Based on diganosis criteria of HCC by Indonesian Association for the Study of the Liver 2017, the patient was diagnosed with HCC Barcelona clinic liver cancer (BCLC) B and was treated with trans arterial chemotherapy and embolization (TACE) with mixed doxorubicin. Aspirin 80mg once daily was given to patient to prevent thrombosis event. One month later after TACE, haemoglobin and haematocrite didn’t improve. Then 4 months later the patient died of cardiovascular event in the last admission at district hospital.

Downloads

Published

2020-07-26

How to Cite

Setiawan, P. B., Maimunah, U., & Siagian, N. (2020). Secondary Polycythemia in Hepatocellular Carcinoma: Treat or No Treat. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 21(1), 64–67. https://doi.org/10.24871/211202064-67

Issue

Vol. 21 No. 1 (2020): VOLUME 21, NUMBER 1, April 2020

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).